Início › Carcinoma Epitelial de Ovário › Nova York
Ensaios clínicos de Carcinoma Epitelial de Ovário em Nova York
10 estudos para Carcinoma Epitelial de Ovário estão buscando participantes em locais em Nova York.
Cidades em Nova York
Texto oficial do estudo (Inglês)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Imbert Cancer Center /ID# 275634, Bay Shore
- Northwell Health Cancer Institute At Huntington /ID# 276814, Greenlawn
- Northwell Health Center for Advanced Medicine. /ID# 275641, Lake Success
- e mais 2
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT06890338Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Mineola
- Avenzo Therapeutics Recruiting Site, New York
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05867251A Study of Isoquercetin in People With Ovarian Cancer
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07303894AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, The Bronx
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 21 de jul. de 2026 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 2 de jul. de 2026 · NCT06819007A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e mais 1
Recrutando
Idades 18 e acima · Mulheres · Atualizado em 1 de jul. de 2026 · NCT05429970A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0173, New York
RecrutandoFase 1
Idades 18 e acima · Mulheres · Atualizado em 7 de abr. de 2026 · NCT04516447A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- Roswell Park Cancer Institute, Buffalo
RecrutandoFase 1
Idades 18 e acima · Mulheres · Atualizado em 3 de fev. de 2026 · NCT06469281Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de ago. de 2025 · NCT04429542Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.